Micrel, the San Jose chip maker who last year successfully fought off a proxy battle with Obrem Capital, its largest independent stockholder, spent $20 million May 7 buying back 3.1 million more of Obrem’s holdings, in addition to the 1.6 million shares it purchased in February.
The company picked up the shares at a discount, Read the rest of this entry »
Micrel is losing the head of its analog business unit next week. Vice President Scott Ward tendered his resignation Monday, a day before the company postponed by a year the expiration date for its poison-pill defense adopted last year in the face of an accumulation of its shares by Obrem Capital, which later launched an unsuccessful proxy battle to take over Micrel’s board.
Ward, 54, joined Micrel 10 years ago and has headed the analog unit since November 2007. There was no explanation offered for why Ward is quitting.
Micrel, the San Jose chip maker that won a nasty proxy battle last year with its then-largest independent shareholder, Obrem Capital, decided it better extend its poison-pill defense against hostile takeovers by one more year. The shareholder rights plan set up a year ago was to have expired today, but will now live on until March 24, 2010, according to a regulatory filing.
On March 19, Micrel entered into a Read the rest of this entry »
Micrel, the San Jose chip maker who last year successfully fought off a proxy battle with Obrem Capital, its largest independent stockholder, spent $10 million this week to buy back 1.6 million of Obrem’s 10.7 million shares.
The company paid Obrem Read the rest of this entry »
Richard Crowley was named chief financial officer of Integrated Device Technology, according to a filing the San Jose chip maker made with the SEC Tuesday. He will begin work Oct. 20, 10 days after he leaves his current employer, Micrel. Crowley gave his notice last week at Micrel, which revealed the decision in its own filing today.
Crowley, 51, has worked at Micrel since 1999 and spent 18 years with Read the rest of this entry »
Micrel, the San Jose chip maker that fought off a proxy challenge earlier this year from Obrem Capital Management, has proposed an amendment to its 2003 “Incentive Award Plan” that would automatically grant an option to purchase one share of its common stock to any independent director on its board for each share the director purchases on the open market, up to a maximum of Read the rest of this entry »
Subscribe via RSS all feeds - Tech feed - O'Brien feed - Docu-Drama feed - Pink Slip 2.0 feed
